Acuitas Therapeutics, Inc. v. CureVac SE
3:23-cv-00764
Overview
Parties
Defendant
Plaintiff
Barbara Mui NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMcGuireWoods LLP
101 W Main St, Suite 9000
Paulo Lin NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMcGuireWoods LLP
101 W Main St, Suite 9000
Ying Tam NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMcGuireWoods LLP
101 W Main St, Suite 9000
Michael Hope NPE (Individual / Inventor)
Represented By
1 Attorneys ListedMcGuireWoods LLP
101 W Main St, Suite 9000
Acuitas Therapeutics, Inc. Operating Company
Represented By
1 Attorneys ListedMcGuireWoods LLP
101 W Main St, Suite 9000
Court & Judges
Court
District Court, E.D. Virginia (vaed)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11241493
Coronavirus vaccine
|
Filed: 2021-04-15
Issued: 2022-02-08
|
Active (14.4 yrs remaining)
Expires: 2041-04-15
|
|
|
US11471525
Coronavirus vaccine
|
Filed: 2021-12-09
Issued: 2022-10-18
|
Active (15.0 yrs remaining)
Expires: 2041-12-09
|
|
|
US11576966
Coronavirus vaccine
|
Filed: 2021-11-15
Issued: 2023-02-14
|
Active (15.0 yrs remaining)
Expires: 2041-11-15
|
|
|
US11596686
Coronavirus vaccine
|
Filed: 2022-08-09
Issued: 2023-03-07
|
Active (14.2 yrs remaining)
Expires: 2041-02-03
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
1
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings